Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 874219-19-9 | MDL No. : | MFCD08235038 |
Formula : | C8H9BFNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DVDSMLPVTUSIFM-UHFFFAOYSA-N |
M.W : | 196.97 | Pubchem ID : | 44717580 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 49.22 |
TPSA : | 69.56 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.36 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.2 |
Log Po/w (WLOGP) : | -0.71 |
Log Po/w (MLOGP) : | 0.22 |
Log Po/w (SILICOS-IT) : | -0.74 |
Consensus Log Po/w : | -0.21 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.31 |
Solubility : | 9.73 mg/ml ; 0.0494 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.22 |
Solubility : | 11.9 mg/ml ; 0.0603 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.96 |
Solubility : | 2.16 mg/ml ; 0.011 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.88 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 874289-11-9 ]
(4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid
Similarity: 0.80
[ 1704063-96-6 ]
(3-((Dimethylamino)methyl)-4-fluorophenyl)boronic acid
Similarity: 0.73
[ 871126-15-7 ]
(3-Fluoro-2-formylphenyl)boronic acid
Similarity: 0.72
[ 871126-22-6 ]
2-Fluoro-4-formylphenylboronic Acid
Similarity: 0.71
[ 1256355-30-2 ]
(5-Fluoro-2-formylphenyl)boronic acid
Similarity: 0.71
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.81
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.81
[ 874289-11-9 ]
(4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid
Similarity: 0.80
[ 373384-14-6 ]
(3-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 405520-68-5 ]
(4-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.81
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.81
[ 874289-11-9 ]
(4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid
Similarity: 0.80
[ 373384-14-6 ]
(3-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 405520-68-5 ]
(4-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.81
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.81
[ 874289-11-9 ]
(4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid
Similarity: 0.80
[ 373384-14-6 ]
(3-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 405520-68-5 ]
(4-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.81
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.81
[ 874289-11-9 ]
(4-(Cyclohexylcarbamoyl)-3-fluorophenyl)boronic acid
Similarity: 0.80
[ 373384-14-6 ]
(3-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79
[ 405520-68-5 ]
(4-(Dimethylcarbamoyl)phenyl)boronic acid
Similarity: 0.79